Rothschild & Co Asset Management US’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $107M | Buy |
|
|||||
|
2022
Q3 | $103M | Sell |
|
|||||
|
2022
Q2 | $120M | Sell |
|
|||||
|
2022
Q1 | $118M | Buy |
|
|||||
|
2021
Q4 | $99M | Sell |
|
|||||
|
2021
Q3 | $94.5M | Sell |
|
|||||
|
2021
Q2 | $108M | Buy |
|
|||||
|
2021
Q1 | $98.8M | Buy |
|
|||||
|
2020
Q4 | $81.5M | Buy |
|
|||||
|
2020
Q3 | $37.4M | Buy |
|
|||||
|
2020
Q2 | $619K | Hold |
|
|||||
|
2020
Q1 | $586K | Hold |
|
|||||
|
2019
Q4 | $675K | Hold |
|
|||||
|
2019
Q3 | $534K | Buy |
|
|||||
|
2019
Q2 | $386K | Buy |
|
|||||
|
2019
Q1 | $351K | Hold |
|
|||||
|
2018
Q4 | $382K | Sell |
|
|||||
|
2018
Q3 | $507K | Hold |
|
|||||
|
2018
Q2 | $452K | Buy |
|
|||||
|
2018
Q1 | $404K | Buy |
|
|||||
|
2017
Q4 | $370K | Hold |
|
|||||
|
2017
Q3 | $385K | Sell |
|
|||||
|
2017
Q2 | $1.37M | Buy |
|
|||||
|
2017
Q1 | $1.3M | Buy |
|
|||||
|
2016
Q4 | $1.29M | Buy |
|
|||||
|
2016
Q3 | $936K | Buy |
|
|||||
|
2016
Q2 | $884K | Buy |
|
|||||
|
2016
Q1 | $736K | Buy |
|
|||||
|
2015
Q4 | $312K | Sell |
|
|||||
|
2015
Q3 | $537K | Hold |
|
|||||
|
2015
Q2 | $604K | Sell |
|
|||||
|
2015
Q1 | $813K | Hold |
|
|||||
|
2014
Q4 | $744K | Sell |
|
|||||
|
2014
Q3 | $794K | Sell |
|
|||||
|
2014
Q2 | $810K | Buy |
|
|||||
|
2014
Q1 | $487K | Sell |
|
|||||
|
2013
Q4 | $6.38M | Sell |
|
|||||
|
2013
Q3 | $11.8M | Sell |
|
|||||
|
2013
Q2 | $31M | Buy |
|